Green tea polyphenols: Biology and therapeutic implications in cancer

Frontiers in Bioscience

Volumn 12, Issue 13, 2007, Pages 4881-4899

  Shankar, Sharmila ^a   Ganapathy, Suthakar ^a   Srivastava, Rakesh K ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Apoptosis; Cancer; Chemoprevention; EGCG; Green tea; Polyphenols; Review

Indexed keywords

ANTINEOPLASTIC AGENT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; ISOLATION AND PURIFICATION; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); REVIEW; SIGNAL TRANSDUCTION; TEA;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CATECHIN; CELL CYCLE; CELL PROLIFERATION; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOLS; SIGNAL TRANSDUCTION; TEA;

EID: 34547680062     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2435     Document Type: Review

References (238)

1. Ahn, W. S., S. W. Huh, S. M. Bae, I. P. Lee, J. M. Lee, S. E. Namkoong, C. K. Kim & J. I. Sin: A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G (1) arrest, and regulation of gene expression. DNA Cell Biol, 22, 217-24 (2003) (Pubitemid 36578095)
2. Manson, M. M., P. B. Farmer, A. Gescher & W. P. Steward: Innovative agents in cancer prevention. Recent Results Cancer Res, 166, 257-75 (2005)
3. Lambert, J. D. & C. S. Yang: Mechanisms of cancer prevention by tea constituents. J Nutr, 133, 3262S-3267S (2003) (Pubitemid 37222254)
4. Muto, S., T. Yokoi, Y. Gondo, M. Katsuki, Y. Shioyama, K. Fujita & T. Kamataki: Inhibition of benzo[a]pyrene-induced mutagenesis by (-) - epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis, 20, 421-4 (1999) (Pubitemid 29112629)
5. Sachinidis, A., C. Seul, S. Seewald, H. Ahn, Y. Ko & H. Vetter: Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett, 471, 51-5 (2000) (Pubitemid 30173291)
6. Ermakova, S., B. Y. Choi, H. S. Choi, B. S. Kang, A. M. Bode & Z. Dong: The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem, 280, 16882-90 (2005) (Pubitemid 41389147)
7. Ermakova, S. P., B. S. Kang, B. Y. Choi, H. S. Choi, T. F. Schuster, W. Y. Ma, A. M. Bode & Z. Dong: (-) - Epigallocatechin gallate overcomes resistance to etoposideinduced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res, 66, 9260-9 (2006) (Pubitemid 44521148)
8. Cao, Y. & R. Cao: Angiogenesis inhibited by drinking tea. Nature, 398:381 (1999)
9. Bode, A. M. & Z. Dong: Targeting signal transduction pathways by chemopreventive agents. Mutat Res, 555, 33-51 (2004) (Pubitemid 39345396)
10. Jung, Y. D. & L. M. Ellis: Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol, 82, 309-16 (2001) (Pubitemid 34063029)
11. Lambert, J. D. & C. S. Yang: Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res, 523-524, 201-8 (2003) (Pubitemid 36293247)
12. Park, O. J. & Y. J. Surh: Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies. Toxicol Lett, 150, 43-56 (2004) (Pubitemid 38447236)
13. Lyn-Cook, B. D., T. Rogers, Y. Yan, E. B. Blann, F. F. Kadlubar & G. J. Hammons: Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer, 35, 80-6 (1999)
14. Qanungo, S., M. Das, S. Haldar & A. Basu: Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis, 26, 958-67 (2005) (Pubitemid 41214325)
15. Tan, M., A. Norwood, M. May, M. Tucci & H. Benghuzzi: Effects of (-) epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture. Biomed Sci Instrum, 42, 363-71 (2006)
16. Takada, M., Y. Nakamura, T. Koizumi, H. Toyama, T. Kamigaki, Y. Suzuki, Y. Takeyama & Y. Kuroda: Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas, 25, 45-8 (2002) (Pubitemid 34760835)
17. Doss, M. X., S. P. Potta, J. Hescheler & A. Sachinidis: Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J Nutr Biochem, 16, 259-66 (2005) (Pubitemid 41556913)
18. Khan, N., F. Afaq, M. Saleem, N. Ahmad & H. Mukhtar: Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3- gallate. Cancer Res, 66, 2500-5 (2006)
19. Korsmeyer, S. J.: Regulators of cell death. Trends Genet, 11, 101-5 (1995)
20. Cory, S. & J. M. Adams: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer, 2, 647-56 (2002) (Pubitemid 37328916)
21. Green, D. R.: Apoptotic pathways: the roads to ruin. Cell, 94, 695-8 (1998)
22. Reed, J. C.: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol, 7, 541-6 (1995)
23. Oltvai, Z. N., C. L. Milliman & S. J. Korsmeyer: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-19 (1993) (Pubitemid 23259742)
24. Jeffers, J. R., E. Parganas, Y. Lee, C. Yang, J. Wang, J. Brennan, K. H. MacLean, J. Han, T. Chittenden, J. N. Ihle, P. J. McKinnon, J. L. Cleveland & G. P. Zambetti: Puma is an essential mediator of p53-dependent and-independent apoptotic pathways. Cancer Cell, 4, 321-8 (2003) (Pubitemid 37329796)
25. Villunger, A., E. M. Michalak, L. Coultas, F. Mullauer, G. Bock, M. J. Ausserlechner, J. M. Adams & A. Strasser: p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science, 302, 1036-8 (2003) (Pubitemid 37386194)
26. Villunger, A., C. Scott, P. Bouillet & A. Strasser: Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood, 101, 2393-400 (2003) (Pubitemid 36302087)
27. Osford, S. M., C. L. Dallman, P. W. Johnson, A. Ganesan & G. Packham: Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr Med Chem, 11, 1031-9 (2004)
28. Chan, S. L. & V. C. Yu: Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol, 31, 119-28 (2004) (Pubitemid 38338707)
29. Kirkin, V., S. Joos & M. Zornig: The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta, 1644, 229-49 (2004) (Pubitemid 38281277)
30. Haldar, S., A. Basu & C. M. Croce: Bcl2 is the guardian of microtubule integrity. Cancer Res, 57, 229-33 (1997) (Pubitemid 27038278)
31. Srivastava, R. K., Q. S. Mi, J. M. Hardwick & D. L. Longo: Deletion of the loop region of Bcl-2 completely blocks 28. paclitaxel-induced apoptosis. Proc Natl Acad Sci U S A, 96, 3775-80 (1999) (Pubitemid 29168986)
32. Srivastava, R. K., C. Y. Sasaki, J. M. Hardwick & D. L. Longo: Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp Med, 190, 253-65 (1999) (Pubitemid 29354918)
33. Srivastava, R. K., S. J. Sollott, L. Khan, R. Hansford, E. G. Lakatta & D. L. Longo: Bcl-2 and Bcl-X (L) block thapsigargin-induced nitric oxide generation, c-Jun. NH (2) - terminal kinase activity, and apoptosis. Mol Cell Biol, 19, 5659-74 (1999) (Pubitemid 29339923)
34. Siddiqui, I. A., N. Zaman, M. H. Aziz, S. R. Reagan-Shaw, S. Sarfaraz, V. M. Adhami, N. Ahmad, S. Raisuddin & H. Mukhtar: Inhibition of CWR22R{nu}1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis, 27, 833-9 (2006)
35. Qin, J., L. P. Xie, X. Y. Zheng, Y. B. Wang, Y. Bai, H. F. Shen, L. C. Li & R. Dahiya: A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun, 354, 852-7 (2007) (Pubitemid 46216211)
36. Zhao, Y., L. F. Yang, M. Ye, H. H. Gu & Y. Cao: Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway. Prev Med, 39, 1172-9 (2004) (Pubitemid 39480669)
37. Chung, J. H., J. H. Han, E. J. Hwang, J. Y. Seo, K. H. Cho, K. H. Kim, J. I. Youn & H. C. Eun: Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. Faseb J, 17, 1913-5 (2003)
38. Baliga, M. S., S. Meleth & S. K. Katiyar: Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res, 11, 1918-27 (2005) (Pubitemid 40471858)
39. Spinella, F., L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali & A. Bagnato: Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol Cancer Ther, 5, 1483-92 (2006) (Pubitemid 44070485)
40. Yu, M., H. Sato, M. Seiki, S. Spiegel & E. W. Thompson: Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett, 412, 568-72 (1997) (Pubitemid 27337111)
41. Chambers, A. F. & L. M. Matrisian: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst, 89, 1260-70 (1997) (Pubitemid 27371946)
42. John, A. & G. Tuszynski: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res, 7, 14-23 (2001) (Pubitemid 32591662)
43. Nelson, A. R., B. Fingleton, M. L. Rothenberg & L. M. Matrisian: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 18, 1135-49 (2000) (Pubitemid 30123793)
44. Kleiner, D. E. & W. G. Stetler-Stevenson: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 43 Suppl, S42-51 (1999) (Pubitemid 29244632)
45. Sternlicht, M. D. & Z. Werb: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 17, 463-516 (2001) (Pubitemid 33096184)
46. Vayalil, P. K. & S. K. Katiyar: Treatment of epigallocatechin-3- gallate inhibits matrix metalloproteinases-2 and-9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells. Prostate, 59, 33-42 (2004) (Pubitemid 38387841)
47. Brawley, O. W., S. Barnes & H. Parnes: The future of prostate cancer prevention. Ann N Y Acad Sci, 952, 145-52 (2001) (Pubitemid 34060017)
48. Yang, J., D. Wei & J. Liu: Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-) - epigallocatechin-3-gallate. Biomed Pharmacother, 59, 98-103 (2005) (Pubitemid 40424556)
49. Corps, A. N., V. A. Curry, D. J. Buttle, B. L. Hazleman & G. P. Riley: Inhibition of interleukin-1beta-stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin gallate ester. Matrix Biol, 23, 163-9 (2004) (Pubitemid 39037251)
50. Adhami, V. M., N. Ahmad & H. Mukhtar: Molecular targets for green tea in prostate cancer prevention. J Nutr, 133, 2417S-2424S (2003) (Pubitemid 36828848)
51. Kim, H. S., M. H. Kim, M. Jeong, Y. S. Hwang, S. H. Lim, B. A. Shin, B. W. Ahn & Y. D. Jung: EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res, 24, 747-53 (2004) (Pubitemid 38625017)
52. Boguski, M. S. & F. McCormick: Proteins regulating Ras and its relatives. Nature, 366, 643-54 (1993) (Pubitemid 24036012)
53. Bokoch, G. M. & C. J. Der: Emerging concepts in the Ras superfamily of GTP-binding proteins. Faseb J, 7, 750-9 (1993) (Pubitemid 23199533)
54. Gibbs, J. B., I. S. Sigal, M. Poe & E. M. Scolnick: Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci U S A, 81, 5704-8 (1984) (Pubitemid 14023834)
55. Shih, C. & R. A. Weinberg: Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell, 29, 161-9 (1982)
56. Campbell, S. L., R. Khosravi-Far, K. L. Rossman, G. J. Clark & C. J. Der: Increasing complexity of Ras signaling. Oncogene, 17, 1395-413 (1998) (Pubitemid 28458409)
57. Schaeffer, H. J. & M. J. Weber: Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol, 19, 2435-44 (1999) (Pubitemid 29144487)
58. Han, J. & R. J. Ulevitch: Emerging targets for antiinflammatory therapy. Nat Cell Biol, 1, E-394. (1999)
59. Davis, R. J.: Signal transduction by the JNK group of MAP kinases. Cell, 103, 239-52 (2000)
60. Chang, L. & M. Karin: Mammalian MAP kinase signalling cascades. Nature, 410, 37-40 (2001) (Pubitemid 32225829)
61. Robinson, M. J. & M. H. Cobb: Mitogen-activated protein kinase pathways. Curr Opin Cell Biol, 9, 180-6 (1997) (Pubitemid 27135985)
62. Woessmann, W., Y. H. Meng & N. F. Mivechi: An essential role for mitogen-activated protein kinases, ERKs, in preventing heat-induced cell death. J Cell Biochem, 74, 648-62 (1999) (Pubitemid 29372504)
63. Kyriakis, J. M. & J. Avruch: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem, 271, 24313-6 (1996) (Pubitemid 26333156)
64. Ono, K. & J. Han: The p38 signal transduction pathway: activation and function. Cell Signal, 12, 1-13 (2000) (Pubitemid 30017963)
65. Lubinus, M., K. E. Meier, E. A. Smith, K. C. Gause, E. C. LeRoy & M. Trojanowska: Independent effects of platelet-derived growth factor isoforms on mitogenactivated protein kinase activation and mitogenesis in human dermal fibroblasts. J Biol Chem, 269, 9822-5 (1994)
66. Chen, C., G. Shen, V. Hebbar, R. Hu, E. D. Owuor & A. N. Kong: Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis, 24, 1369-78 (2003) (Pubitemid 37045317)
67. Yamamoto, T., H. Digumarthi, Z. Aranbayeva, J. Wataha, J. Lewis, R. Messer, H. Qin, D. Dickinson, T. Osaki, G. S. Schuster & S. Hsu: EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: Role of c-Jun. N-terminal kinase. Toxicol Appl Pharmacol (2006)
68. Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler & R. Parsons: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-7 (1997) (Pubitemid 27148818)
69. Steck, P. A., M. A. Pershouse, S. A. Jasser, W. K. Yung, H. Lin, A. H. Ligon, L. A. Langford, M. L. Baumgard, T. Hattier, T. Davis, C. Frye, R. Hu, B. Swedlund, D. H. Teng & S. V. Tavtigian: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancers. Nat Genet, 15, 356-62 (1997) (Pubitemid 27147102)
70. Li, D. M. & H. Sun: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res, 57, 2124-9 (1997) (Pubitemid 27247025)
71. Wang, S. I., J. Puc, J. Li, J. N. Bruce, P. Cairns, D. Sidransky & R. Parsons: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res, 57, 4183-6 (1997) (Pubitemid 27413419)
72. Guldberg, P., P. thor Straten, A. Birck, V. Ahrenkiel, A. F. Kirkin & J. Zeuthen: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res, 57, 3660-3 (1997) (Pubitemid 27381203)
73. Cairns, P., K. Okami, S. Halachmi, N. Halachmi, M. Esteller, J. G. Herman, J. Jen, W. B. Isaacs, G. S. Bova & D. Sidransky: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res, 57, 4997-5000 (1997) (Pubitemid 27498107)
74. Rhei, E., L. Kang, F. Bogomolniy, M. G. Federici, P. I. Borgen & J. Boyd: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res, 57, 3657-9 (1997) (Pubitemid 27381202)
75. Tashiro, H., M. S. Blazes, R. Wu, K. R. Cho, S. Bose, S. I. Wang, J. Li, R. Parsons & L. H. Ellenson: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 57, 3935-40 (1997) (Pubitemid 27427679)
76. Liaw, D., D. J. Marsh, J. Li, P. L. Dahia, S. I. Wang, Z. Zheng, S. Bose, K. M. Call, H. C. Tsou, M. Peacocke, C. Eng & R. Parsons: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet, 16, 64-7 (1997) (Pubitemid 27198157)
77. Marsh, D. J., P. L. Dahia, Z. Zheng, D. Liaw, R. Parsons, R. J. Gorlin & C. Eng: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet, 16, 333-4 (1997)
78. Di Cristofano, A., B. Pesce, C. Cordon-Cardo & P. P. Pandolfi: Pten is essential for embryonic development and tumour suppression. Nat Genet, 19, 348-55 (1998) (Pubitemid 28357906)
79. Suzuki, A., J. L. de la Pompa, V. Stambolic, A. J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, W. Khoo, M. Fukumoto & T. W. Mak: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol, 8, 1169-78 (1998) (Pubitemid 28494715)
80. Podsypanina, K., L. H. Ellenson, A. Nemes, J. Gu, M. Tamura, K. M. Yamada, C. Cordon-Cardo, G. Catoretti, P. E. Fisher & R. Parsons: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A, 96, 1563-8 (1999) (Pubitemid 29098491)
81. Maehama, T. & J. E. Dixon: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem, 273, 13375-8 (1998) (Pubitemid 28268370)
82. Stambolic, V., A. Suzuki, J. L. de la Pompa, G. M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J. M. Penninger, D. P. Siderovski & T. W. Mak: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95, 29-39 (1998) (Pubitemid 28458022)
83. Tamura, M., J. Gu, K. Matsumoto, S. Aota, R. Parsons & K. M. Yamada: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 280, 1614-7 (1998) (Pubitemid 28277707)
84. Teng, D. H., R. Hu, H. Lin, T. Davis, D. Iliev, C. Frye, B. Swedlund, K. L. Hansen, V. L. Vinson, K. L. Gumpper, L. Ellis, A. El-Naggar, M. Frazier, S. Jasser, L. A. Langford, J. Lee, G. B. Mills, M. A. Pershouse, R. E. Pollack, C. Tornos, P. Troncoso, W. K. Yung, G. Fujii, A. Berson, P. A. Steck & et al.: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res, 57, 5221-5 (1997) (Pubitemid 27516352)
85. Gu, J., M. Tamura & K. M. Yamada: Tumor suppressor PTEN inhibits integrin-and growth factor-mediated mitogenactivated protein (MAP) kinase signaling pathways. J Cell Biol, 143, 1375-83 (1998) (Pubitemid 28559837)
86. Chen, X., H. Thakkar, F. Tyan, S. Gim, H. Robinson, C. Lee, S. K. Pandey, C. Nwokorie, N. Onwudiwe & R. K. Srivastava: Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene, 20, 6073-83 (2001) (Pubitemid 32955050)
87. Downward, J.: PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol, 15, 177-82 (2004) (Pubitemid 38251646)
88. Harrington, L. S., G. M. Findlay & R. F. Lamb: Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci, 30, 35-42 (2005) (Pubitemid 40093739)
89. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan & M. E. Greenberg: Regulation of neuronal survival by the serinethreonine protein kinase Akt. Science, 275, 661-5 (1997) (Pubitemid 27061332)
90. Kaufmann, S. H. & M. O. Hengartner: Programmed cell death: alive and well in the new millennium. Trends Cell Biol, 11, 526-34 (2001) (Pubitemid 33079147)
91. Kennedy, S. G., A. J. Wagner, S. D. Conzen, J. Jordan, A. Bellacosa, P. N. Tsichlis & N. Hay: The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev, 11, 701-13 (1997) (Pubitemid 27157159)
92. Khwaja, A.: Akt is more than just a Bad kinase. Nature, 401, 33-4 (1999)
93. Kulik, G. & M. J. Weber: Akt-dependent and - independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol, 18, 6711-8 (1998) (Pubitemid 28500558)
94. Kandasamy, K. & R. K. Srivastava: Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligandinduced apoptosis in non-small cell lung cancer cells. Cancer Res, 62, 4929-37 (2002) (Pubitemid 34984416)
95. Asano, T., Y. Yao, J. Zhu, D. Li, J. L. Abbruzzese & S. A. Reddy: The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene, 23, 8571-80 (2004) (Pubitemid 39576463)
96. Cicenas, J., P. Urban, V. Vuaroqueaux, M. Labuhn, W. Kung, E. Wight, M. Mayhew, U. Eppenberger & S. Eppenberger-Castori: Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Res, 7, R-39440. (2005)
97. Semba, S., T. Moriya, W. Kimura & M. Yamakawa: Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas. Pancreas, 26, 250-7 (2003) (Pubitemid 36384157)
98. Yao, Z., Y. Okabayashi, Y. Yutsudo, T. Kitamura, W. Ogawa & M. Kasuga: Role of Akt in growth and survival of PANC-1 pancreatic cancer cells. Pancreas, 24, 42-6 (2002) (Pubitemid 34019658)
99. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh & M. E. Greenberg: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-41 (1997) (Pubitemid 27456390)
100. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera & G. Nunez: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-9 (1997) (Pubitemid 27464966)
101. Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch & J. C. Reed: Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-21 (1998) (Pubitemid 28524494)
102. Kang, S. S., T. Kwon, D. Y. Kwon & S. I. Do: Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem, 274, 13085-90 (1999)
103. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis & M. E. Greenberg: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-68 (1999) (Pubitemid 29165088)
104. Kops, G. J., N. D. de Ruiter, A. M. De Vries-Smits, D. R. Powell, J. L. Bos & B. M. Burgering: Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature, 398, 630-4 (1999) (Pubitemid 29183692)
105. Romashkova, J. A. & S. S. Makarov: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature, 401, 86-90 (1999)
106. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer & D. B. Donner: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature, 401, 82-5 (1999)
107. Sah, J. F., S. Balasubramanian, R. L. Eckert & E. A. Rorke: Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem, 279, 12755-62 (2004) (Pubitemid 38445847)
108. Bigelow, R. L. & J. A. Cardelli: The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-) - Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene, 25, 1922-30 (2006)
109. Siddiqui, I. A., V. M. Adhami, F. Afaq, N. Ahmad & H. Mukhtar: Modulation of phosphatidylinositol-3-kinase/protein kinase B-and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem, 91, 232-42 (2004)
110. Zhang, Q., X. Tang, Q. Lu, Z. Zhang, J. Rao & A. D. Le: Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia-and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther, 5, 1227-38 (2006) (Pubitemid 43881315)
111. Masamune, A., K. Kikuta, M. Satoh, N. Suzuki & T. Shimosegawa: Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol, 11, 3368-74 (2005) (Pubitemid 40873241)
112. Masuda, M., M. Suzui, J. T. Lim, A. Deguchi, J. W. Soh & I. B. Weinstein: Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol, 2, 350-9 (2002) (Pubitemid 35265984)
113. Cuendet, M. & J. M. Pezzuto: The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact, 17, 109-57 (2000) (Pubitemid 32049022)
114. Hussain, T., S. Gupta, V. M. Adhami & H. Mukhtar: Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer, 113, 660-9 (2005) (Pubitemid 40038745)
115. Jeong, Y. I., I. D. Jung, J. S. Lee, C. M. Lee, J. D. Lee & Y. M. Park: (-)-Epigallocatechin gallate suppresses indoleamine 2, 3-dioxygenase expression in murine dendritic cells: Evidences for the COX-2 and STAT1 as potential targets. Biochem Biophys Res Commun, 354, 1004-9 (2007) (Pubitemid 46216233)
116. Peng, G., D. A. Dixon, S. J. Muga, T. J. Smith & M. J. Wargovich: Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog, 45, 309-19 (2006)
117. Hwang, J. T., J. Ha, I. J. Park, S. K. Lee, H. W. Baik, Y. M. Kim & O. J. Park: Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett, 247, 115-21 (2007) (Pubitemid 46001507)
118. Suganuma, M., M. Kurusu, K. Suzuki, E. Tasaki & H. Fujiki: Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer, 119, 33-40 (2006)
119. Ullrich, A., L. Coussens, J. S. Hayflick, T. J. Dull, A. Gray, A. W. Tam, J. Lee, Y. Yarden, T. A. Libermann, J. Schlessinger & et al.: Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418-25 (1984) (Pubitemid 14102443)
120. Saloman, D. S., C. Bianco, A. D. Ebert, N. I. Khan, M. De Santis, N. Normanno, C. Wechselberger, M. Seno, K. Williams, M. Sanicola, S. Foley, W. J. Gullick & G. Persico: The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer, 7, 199-226 (2000) (Pubitemid 32172272)
121. Wells, A.: EGF receptor. Int J Biochem Cell Biol, 31, 637-43 (1999) (Pubitemid 29248872)
122. Ullrich, A. & J. Schlessinger: Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-12 (1990)
123. Shimizu, M., A. Deguchi, J. T. Lim, H. Moriwaki, L. Kopelovich & I. B. Weinstein: (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res, 11, 2735-46 (2005) (Pubitemid 40569476)
124. Masuda, M., M. Suzui & I. B. Weinstein: Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res, 7, 4220-9 (2001) (Pubitemid 34044648)
125. Ichimatsu, D., M. Nomura, S. Nakamura, S. Moritani, K. Yokogawa, S. Kobayashi, T. Nishioka & K. I. Miyamoto: Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells. Mol Carcinog (2007)
126. Pollak, M. N., E. S. Schernhammer & S. E. Hankinson: Insulin-like growth factors and neoplasia. Nat Rev Cancer, 4, 505-18 (2004) (Pubitemid 38868620)
127. Leng, S. L., K. S. Leeding, P. R. Gibson & L. A. Bach: Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. Carcinogenesis, 22, 1625-31 (2001) (Pubitemid 32952139)
128. Tanno, S., S. Tanno, Y. Mitsuuchi, D. A. Altomare, G. H. Xiao & J. R. Testa: AKT activation up-regulates insulinlike growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res, 61, 589-93 (2001) (Pubitemid 32128619)
129. Wu, J. D., A. Odman, L. M. Higgins, K. Haugk, R. Vessella, D. L. Ludwig & S. R. Plymate: In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors. Clin Cancer Res, 11, 3065-74 (2005) (Pubitemid 40525213)
130. Min, Y., Y. Adachi, H. Yamamoto, A. Imsumran, Y. Arimura, T. Endo, Y. Hinoda, C. T. Lee, S. Nadaf, D. P. Carbone & K. Imai: Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts. Gut, 54, 591-600 (2005) (Pubitemid 40559239)
131. Bahr, C. & B. Groner: The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy. Growth Horm IGF Res, 14, 287-95 (2004) (Pubitemid 38878054)
132. Hernandez-Sanchez, C., V. Blakesley, T. Kalebic, L. Helman & D. LeRoith: The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis. J Biol Chem, 270, 29176-81 (1995)
133. Larsson, O., A. Girnita & L. Girnita: Role of insulinlike growth factor 1 receptor signalling in cancer. Br J Cancer, 92, 2097-101 (2005) (Pubitemid 40966242)
134. Li, M., Z. He, S. Ermakova, D. Zheng, F. Tang, Y. Y. Cho, F. Zhu, W. Y. Ma, Y. Sham, E. A. Rogozin, A. M. Bode, Y. Cao & Z. Dong: Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-) - epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev, 16, 598-605 (2007) (Pubitemid 46548666)
135. Adhami, V. M., I. A. Siddiqui, N. Ahmad, S. Gupta & H. Mukhtar: Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res, 64, 8715-22 (2004) (Pubitemid 39552088)
136. Yokoyama, S., H. Hirano, N. Wakimaru, K. P. Sarker & J. Kuratsu: Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro. Neuro-oncol, 3, 22-8 (2001) (Pubitemid 33685582)
137. Lin, J. K., Y. C. Liang & S. Y. Lin-Shiau: Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol, 58, 911-5 (1999)
138. Ahn, S. C., G. Y. Kim, J. H. Kim, S. W. Baik, M. K. Han, H. J. Lee, D. O. Moon, C. M. Lee, J. H. Kang, B. H. Kim, Y. H. Oh & Y. M. Park: Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem Biophys Res Commun, 313, 148-55 (2004)
139. Yan, Z., T. Yong-Guang, L. Fei-Jun, T. Fa-Qing, T. Min & C. Ya: Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1. Int J Biochem Cell Biol, 36, 1473-81 (2004) (Pubitemid 38625827)
140. Gupta, S., K. Hastak, F. Afaq, N. Ahmad & H. Mukhtar: Essential role of caspases in epigallocatechin-3-gallatemediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene, 23, 2507-22 (2004) (Pubitemid 38520748)
141. Ahmad, N., S. Gupta & H. Mukhtar: Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys, 376, 338-46 (2000) (Pubitemid 30210882)
142. Song, X. Z., Z. G. Bi & A. E. Xu: Green tea polyphenol epigallocatechin-3-gallate inhibits the expression of nitric oxide synthase and generation of nitric oxide induced by ultraviolet B in HaCaT cells. Chin Med J (Engl), 119, 282-7 (2006)
143. Wheeler, D. S., J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra & H. R. Wong: Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr, 134, 1039-44 (2004) (Pubitemid 38619936)
144. Afaq, F., V. M. Adhami, N. Ahmad & H. Mukhtar: Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene, 22, 1035-44 (2003) (Pubitemid 36313147)
145. Syed, D. N., F. Afaq, M. H. Kweon, N. Hadi, N. Bhatia, V. S. Spiegelman & H. Mukhtar: Green tea polyphenol EGCG suppresses cigarette smoke condensateinduced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene, 26, 673-82 (2007) (Pubitemid 46204247)
146. Yu, C. L., D. J. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz & R. Jove: Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science, 269, 81-3 (1995)
147. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem & J. E. Darnell, Jr.: Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol, 18, 2553-8 (1998) (Pubitemid 28183425)
148. Grandis, J. R., S. D. Drenning, A. Chakraborty, M. Y. Zhou, Q. Zeng, A. S. Pitt & D. J. Tweardy: Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth In vitro. J Clin Invest, 102, 1385-92 (1998) (Pubitemid 28467567)
149. Carlesso, N., D. A. Frank & J. D. Griffin: Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med, 183, 811-20 (1996) (Pubitemid 26113953)
150. Weber-Nordt, R. M., C. Egen, J. Wehinger, W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann & J. Finke: Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood, 88, 809-16 (1996) (Pubitemid 26333300)
151. Bharti, A. C., N. Donato & B. B. Aggarwal: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol, 171, 3863-71 (2003) (Pubitemid 37254592)
152. Stephanou, A.: Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J Cell Mol Med, 8, 519-25 (2004) (Pubitemid 44145484)
153. Townsend, P. A., T. M. Scarabelli, E. Pasini, G. Gitti, M. Menegazzi, H. Suzuki, R. A. Knight, D. S. Latchman & A. Stephanou: Epigallocatechin-3- gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. Faseb J, 18, 1621-3 (2004) (Pubitemid 39561653)
154. Karin, M., Z. Liu & E. Zandi: AP-1 function and regulation. Curr Opin Cell Biol, 9, 240-6 (1997) (Pubitemid 27135992)
155. Dong, Z., M. J. Birrer, R. G. Watts, L. M. Matrisian & N. H. Colburn: Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A, 91, 609-13 (1994) (Pubitemid 24041451)
156. Huang, C., W. Y. Ma, M. R. Young, N. Colburn & Z. Dong: Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci U SA, 95, 156-61 (1998) (Pubitemid 28103923)
157. Dumont, J. A., A. J. Bitonti, C. D. Wallace, R. J. Baumann, E. A. Cashman & D. E. Cross-Doersen: Progression of MCF-7 breast cancer cells to antiestrogenresistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity. Cell Growth Differ, 7, 351-9 (1996) (Pubitemid 26360774)
158. Saez, E., S. E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S. H. Yuspa & B. M. Spiegelman: c-fos is required for malignant progression of skin tumors. Cell, 82, 721-32 (1995)
159. Crawford, H. C. & L. M. Matrisian: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein, 49, 20-37 (1996) (Pubitemid 26181735)
160. Wright, J. H., S. McDonnell, G. Portella, G. T. Bowden, A. Balmain & L. M. Matrisian: A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol Carcinog, 10, 207-15 (1994) (Pubitemid 24283036)
161. Dong, Z., W. Ma, C. Huang & C. S. Yang: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-) - epigallocatechin gallate, and theaflavins. Cancer Res, 57, 4414-9 (1997) (Pubitemid 27413453)
162. Eckert, R. L., J. F. Crish, T. Efimova & S. Balasubramanian: Opposing action of curcumin and green tea polyphenol in human keratinocytes. Mol Nutr Food Res, 50, 123-9 (2006) (Pubitemid 43325653)
163. Balasubramanian, S., T. Efimova & R. L. Eckert: Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factordependent involucrin gene expression in normal human keratinocytes. J Biol Chem, 277, 1828-36 (2002) (Pubitemid 34968756)
164. Lee, J. S. & Y. J. Surh: Nrf2 as a novel molecular target for chemoprevention. Cancer Lett, 224, 171-84 (2005)
165. Kobayashi, A., M. I. Kang, Y. Watai, K. I. Tong, T. Shibata, K. Uchida & M. Yamamoto: Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol, 26, 221-9 (2006)
166. Martin, D., A. I. Rojo, M. Salinas, R. Diaz, G. Gallardo, J. Alam, C. M. De Galarreta & A. Cuadrado: Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem, 279, 8919-29 (2004) (Pubitemid 38295953)
167. Kweon, M. H., V. M. Adhami, J. S. Lee & H. Mukhtar: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem, 281, 33761-72 (2006) (Pubitemid 46036754)
168. Cho, H. Y., S. P. Reddy, M. Yamamoto & S. R. Kleeberger: The transcription factor NRF2 protects against pulmonary fibrosis. Faseb J, 18, 1258-60 (2004) (Pubitemid 39561569)
169. Ahmad, N., D. K. Feyes, A. L. Nieminen, R. Agarwal & H. Mukhtar: Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst, 89, 1881-6 (1997) (Pubitemid 28009824)
170. Yang, C. S., P. Maliakal & X. Meng: Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol, 42, 25-54 (2002) (Pubitemid 34160518)
171. Gupta, S., T. Hussain & H. Mukhtar: Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys, 410, 177-85 (2003) (Pubitemid 36268810)
172. Xu, F. & Y. S. Zhen: (-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytosine arabinoside on HL-60 cells. Acta Pharmacol Sin, 24, 163-8 (2003) (Pubitemid 36168365)
173. Liang, Y. C., S. Y. Lin-Shiau, C. F. Chen & J. K. Lin: Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-) - epigallocatechin-3-gallate. J Cell Biochem, 75, 1-12 (1999)
174. Hofmann, C. S. & G. E. Sonenshein: Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. Faseb J, 17, 702-4 (2003)
175. Roy, A. M., M. S. Baliga & S. K. Katiyar: Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther, 4, 81-90 (2005) (Pubitemid 40268069)
176. Sen, P., P. K. Chakraborty & S. Raha: Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways. FEBS Lett, 580, 278-84 (2006) (Pubitemid 43005350)
177. Kuhn, D., W. H. Lam, A. Kazi, K. G. Daniel, S. Song, L. M. Chow, T. H. Chan & Q. P. Dou: Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. Front Biosci, 10, 1010-23 (2005)
178. Gupta, S., N. Ahmad, A. L. Nieminen & H. Mukhtar: Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol, 164, 82-90 (2000) (Pubitemid 30198547)
179. Tam, N. N., A. Nyska, R. R. Maronpot, G. Kissling, L. Lomnitski, A. Suttie, S. Bakshi, M. Bergman, S. Grossman & S. M. Ho: Differential attenuation of oxidative/nitrosative injuries in early prostatic neoplastic lesions in TRAMP mice by dietary antioxidants. Prostate, 66, 57-69 (2006) (Pubitemid 43005949)
180. Pezzato, E., L. Sartor, I. Dell'Aica, R. Dittadi, M. Gion, C. Belluco, M. Lise & S. Garbisa: Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-) epigallocatechin-3-gallate. Int J Cancer, 112, 787-92 (2004) (Pubitemid 39435263)
181. Caporali, A., P. Davalli, S. Astancolle, D. D'Arca, M. Brausi, S. Bettuzzi & A. Corti: The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis, 25, 2217-24 (2004) (Pubitemid 39534860)
182. Yu, H. N., J. J. Yin & S. R. Shen: Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+. J Agric Food Chem, 52, 462-6 (2004)
183. Yu, H. N., S. R. Shen & J. J. Yin: Effects of interactions of EGCG and Cd (2+) on the growth of PC-3 cells and their mechanisms. Food Chem Toxicol, 45, 244-9 (2007)
184. Stuart, E. C., M. J. Scandlyn & R. J. Rosengren: Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci, 79, 2329-36 (2006) (Pubitemid 44772933)
185. Henning, S. M., W. Aronson, Y. Niu, F. Conde, N. H. Lee, N. P. Seeram, R. P. Lee, J. Lu, D. M. Harris, A. Moro, J. Hong, L. Pak-Shan, R. J. Barnard, H. G. Ziaee, G. Csathy, V. L. Go, H. Wang & D. Heber: Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr, 136, 1839-43 (2006) (Pubitemid 43973585)
186. Wang, S. I. & H. Mukhtar: Gene expression profile in human prostate LNCaP cancer cells by (-) epigallocatechin-3-gallate. Cancer Lett, 182, 43-51 (2002) (Pubitemid 34518655)
187. Ren, F., S. Zhang, S. H. Mitchell, R. Butler & C. Y. Young: Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene, 19, 1924-32 (2000) (Pubitemid 30219035)
188. Chung, F. L.: The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black Tea. Proc Soc Exp Biol Med, 220, 244-8 (1999)
189. Sazuka, M., S. Murakami, M. Isemura, K. Satoh & T. Nukiwa: Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett, 98, 27-31 (1995)
190. Zhang, Z., Q. Liu, L. E. Lantry, Y. Wang, G. J. Kelloff, M. W. Anderson, R. W. Wiseman, R. A. Lubet & M. You: A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res, 60, 901-7 (2000) (Pubitemid 30129524)
191. Hu, G., C. Han & J. Chen: Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. Nutr Cancer, 24, 203-9 (1995)
192. Mukhtar, H. & C. A. Elmets: Photocarcinogenesis: mechanisms, models and human health implications. Photochem Photobiol, 63, 356-7 (1996) (Pubitemid 126468292)
193. Katiyar, S. K., M. S. Matsui, C. A. Elmets & H. Mukhtar: Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol, 69, 148-53 (1999) (Pubitemid 129606899)
194. Katiyar, S., C. A. Elmets & S. K. Katiyar: Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem (2006)
195. Meeran, S. M., S. K. Mantena & S. K. Katiyar: Prevention of ultraviolet radiation-induced immunosuppression by (-)-epigallocatechin-3- gallate in mice is mediated through interleukin 12-dependent DNA repair. Clin Cancer Res, 12, 2272-80 (2006)
196. Warshaw, A. L. & C. Fernandez-del Castillo: Pancreatic carcinoma. N Engl J Med, 326, 455-65 (1992)
197. Magee, C. J., P. Ghaneh & J. P. Neoptolemos: Surgical and medical therapy for pancreatic carcinoma. Best Pract Res Clin Gastroenterol, 16, 435-55 (2002)
198. Yeo, T. P., R. H. Hruban, S. D. Leach, R. E. Wilentz, T. A. Sohn, S. E. Kern, C. A. Iacobuzio-Donahue, A. Maitra, M. Goggins, M. I. Canto, R. A. Abrams, D. Laheru, E. M. Jaffee, M. Hidalgo & C. J. Yeo: Pancreatic cancer. Curr Probl Cancer, 26, 176-275 (2002)
199. Hruban, R. H., N. V. Adsay, J. Albores-Saavedra, C. Compton, E. S. Garrett, S. N. Goodman, S. E. Kern, D. S. Klimstra, G. Kloppel, D. S. Longnecker, J. Luttges & G. J. Offerhaus: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol, 25, 579-86 (2001) (Pubitemid 32423354)
200. Bardeesy, N. & R. A. DePinho: Pancreatic cancer biology and genetics. Nat Rev Cancer, 2, 897-909 (2002) (Pubitemid 37328891)
201. Hilgers, W. & S. E. Kern: Molecular genetic basis of pancreatic adenocarcinoma. Genes Chromosomes Cancer, 26, 1-12 (1999) (Pubitemid 29374856)
202. Cubilla, A. L. & P. J. Fitzgerald: Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res, 36, 2690-8 (1976)
203. Yoshida, T. & D. Hanahan: Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am J Pathol, 145, 671-84 (1994) (Pubitemid 24285974)
204. Pour, P. M., K. K. Pandey & S. K. Batra: What is the origin of pancreatic adenocarcinoma? Mol Cancer, 2:13 (2003)
205. Meszoely, I. M., A. L. Means, C. R. Scoggins & S. D. Leach: Developmental aspects of early pancreatic cancer. Cancer J, 7, 242-50 (2001)
206. Wagner, M., F. R. Greten, C. K. Weber, S. Koschnick, T. Mattfeldt, W. Deppert, H. Kern, G. Adler & R. M. Schmid: A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev, 15, 286-93 (2001) (Pubitemid 32155144)
207. Bockman, D. E., J. Guo, P. Buchler, M. W. Muller, F. Bergmann & H. Friess: Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest, 83, 853-9 (2003) (Pubitemid 36723694)
208. Leach, S. D.: Mouse models of pancreatic cancer: the fur is finally flying! Cancer Cell, 5, 7-11 (2004) (Pubitemid 38121591)
209. Miyamoto, Y., A. Maitra, B. Ghosh, U. Zechner, P. Argani, C. A. Iacobuzio-Donahue, V. Sriuranpong, T. Iso, I. M. Meszoely, M. S. Wolfe, R. H. Hruban, D. W. Ball, R. M. Schmid & S. D. Leach: Notch mediates TGF alphainduced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell, 3, 565-76 (2003) (Pubitemid 36808651)
210. Conney, A. H.: Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the Seventh DeWitt S. Goodman Lecture. Cancer Res, 63, 7005-31 (2003) (Pubitemid 37413433)
211. Mittal, A., M. S. Pate, R. C. Wylie, T. O. Tollefsbol & S. K. Katiyar: EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol, 24, 703-10 (2004)
212. Chen, Z. P., J. B. Schell, C. T. Ho & K. Y. Chen: Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett, 129, 173-9 (1998) (Pubitemid 28386599)
213. Kavanagh, K. T., L. J. Hafer, D. W. Kim, K. K. Mann, D. H. Sherr, A. E. Rogers & G. E. Sonenshein: Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem, 82, 387-98 (2001) (Pubitemid 32729403)
214. Thangapazham, R. L., A. K. Singh, A. Sharma, J. Warren, J. P. Gaddipati & R. K. Maheshwari: Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett, 245, 232-41 (2007) (Pubitemid 44959362)
215. Zhao, X., H. Tian, X. Ma & L. Li: Epigallocatechin gallate, the main ingredient of green tea induces apoptosis in breast cancer cells. Front Biosci, 11, 2428-33 (2006) (Pubitemid 43806556)
216. Guo, S., J. Lu, A. Subramanian & G. E. Sonenshein: Microarray-assisted pathway analysis identifies mitogenactivated protein kinase signaling as a mediator of resistance to the green tea polyphenol epigallocatechin 3-gallate in her-2/neu-overexpressing breast cancer cells. Cancer Res, 66, 5322-9 (2006) (Pubitemid 43844957)
217. Kim, J., X. Zhang, K. M. Rieger-Christ, I. C. Summerhayes, D. E. Wazer, K. E. Paulson & A. S. Yee: Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem, 281, 10865-75 (2006) (Pubitemid 43855509)
218. Lin, J. K. & S. Y. Lin-Shiau: Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res, 50, 211-7 (2006)
219. Huh, S. W., S. M. Bae, Y. W. Kim, J. M. Lee, S. E. Namkoong, I. P. Lee, S. H. Kim, C. K. Kim & W. S. Ahn: Anticancer effects of (-)- epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol, 94, 760-8 (2004) (Pubitemid 39194472)
220. Spinella, F., L. Rosano, S. Decandia, V. Di Castro, A. Albini, G. Elia, P. G. Natali & A. Bagnato: Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target. Exp Biol Med (Maywood), 231, 1123-7 (2006) (Pubitemid 43845590)
221. Chan, M. M., K. J. Soprano, K. Weinstein & D. Fong: Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol, 207, 389-96 (2006)
222. Kalluri, R. & V. P. Sukhatme: Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens, 9, 413-8 (2000) (Pubitemid 30451697)
223. Folkman, J.: Angiogenesis and proteins of the hemostatic system. J Thromb Haemost, 1, 1681-2 (2003)
224. Lee, Y. K., N. D. Bone, A. K. Strege, T. D. Shanafelt, D. F. Jelinek & N. E. Kay: VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood, 104, 788-94 (2004) (Pubitemid 38970575)
225. Jung, Y. D., M. S. Kim, B. A. Shin, K. O. Chay, B. W. Ahn, W. Liu, C. D. Bucana, G. E. Gallick & L. M. Ellis: EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer, 84, 844-50 (2001) (Pubitemid 32275661)
226. Fassina, G., R. Vene, M. Morini, S. Minghelli, R. Benelli, D. M. Noonan & A. Albini: Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin Cancer Res, 10, 4865-73 (2004) (Pubitemid 38955541)
227. Neuhaus, T., S. Pabst, S. Stier, A. A. Weber, K. Schror, A. Sachinidis, H. Vetter & Y. D. Ko: Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol, 483, 223-7 (2004) (Pubitemid 38068403)
228. Rodriguez, S. K., W. Guo, L. Liu, M. A. Band, E. K. Paulson & M. Meydani: Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer, 118, 1635-44 (2006) (Pubitemid 43376426)
229. Park, J. S., M. H. Kim, H. J. Chang, K. M. Kim, S. M. Kim, B. A. Shin, B. W. Ahn & Y. D. Jung: Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2. Int J Oncol, 29, 1247-52 (2006)
230. Annabi, B., Y. T. Lee, C. Martel, A. Pilorget, J. P. Bahary & R. Beliveau: Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3- gallate. Cancer Biol Ther, 2, 642-9 (2003)
231. Changotade, S. I., A. Assoumou, F. Gueniche, F. Fioretti, S. Seguier, Y. de Prost, C. Bodemer, G. Godeau & K. Senni: Epigallocatechin Gallate's Protective Effect against MMP7 in Recessive Dystrophic Epidermolysis Bullosa Patients. J Invest Dermatol, 127, 821-8 (2007) (Pubitemid 46434659)
232. Annabi, B., J. C. Currie, A. Moghrabi & R. Beliveau: Inhibition of HuR and MMP-9 expression in macrophagedifferentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk Res (2006)
233. Ngameni, B., M. Touaibia, R. Patnam, A. Belkaid, P. Sonna, B. T. Ngadjui, B. Annabi & R. Roy: Inhibition of MMP-2 secretion from brain tumor cells suggests chemopreventive properties of a furanocoumarin glycoside and of chalcones isolated from the twigs of Dorstenia turbinata. Phytochemistry, 67, 2573-9 (2006) (Pubitemid 44711963)
234. Roomi, M. W., V. Ivanov, T. Kalinovsky, A. Niedzwiecki & M. Rath: Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro. Med Oncol, 23, 245-50 (2006) (Pubitemid 43780308)
235. Kim, S. H., H. J. Park, C. M. Lee, I. W. Choi, D. O. Moon, H. J. Roh, H. K. Lee & Y. M. Park: Epigallocatechin-3-gallate protects toluene diisocyanateinduced airway inflammation in a murine model of asthma. FEBS Lett, 580, 1883-90 (2006)
236. Zhen, M. C., X. H. Huang, Q. Wang, K. Sun, Y. J. Liu, W. Li, L. J. Zhang, L. Q. Cao & X. L. Chen: Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta Pharmacol Sin, 27, 1600-7 (2006) (Pubitemid 44813898)
237. Tang, F. Y., E. P. Chiang & C. J. Shih: Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. J Nutr Biochem (2006)
238. Matsubara, K., A. Saito, A. Tanaka, N. Nakajima, R. Akagi, M. Mori & Y. Mizushina: Catechin conjugated with fatty acid inhibits DNA polymerase and angiogenesis. DNA Cell Biol, 25, 95-103 (2006) (Pubitemid 43271413)